Breaking News Instant updates and real-time market news.

HOG

Harley-Davidson

$35.75 /

-2.665 (-6.94%)

09:14
05/19/22
05/19
09:14
05/19/22
09:14

Harley-Davidson sinks 10% after suspending all vehicle assembly

Shares of Harley-Davidson are moving lower after the company said it suspended yesterday all vehicle assembly and shipments, excluding LiveWire, for a two-week period. "This decision, taken out of an abundance of caution, is based on information provided by a third-party supplier to Harley-Davidson late on Tuesday (5/17) concerning a regulatory compliance matter relating to the supplier's component part," Harley-Davidson noted in a statement. Shares of the company are down 10%, or $3.75, to $32.00 in premarket trading.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Vontier appoints Anshooman Aga as CFO » 08:05
08/12/22
08/12
08:05
08/12/22
08:05
VNT

Vontier

$24.16 /

-0.315 (-1.29%)

, HSC

Harsco

$6.56 /

+0.04 (+0.61%)

Vontier (VNT) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VNT Vontier
$24.16 /

-0.315 (-1.29%)

HSC Harsco
$6.56 /

+0.04 (+0.61%)

VNT Vontier
$24.16 /

-0.315 (-1.29%)

07/08/22 Barclays
Vontier price target lowered to $33 from $39 at Barclays
04/04/22 Barclays
Vontier price target lowered to $40 from $42 at Barclays
03/23/22 Argus
Vontier price target lowered to $30 from $40 at Argus
02/18/22 Citi
Vontier price target lowered to $34 from $39 at Citi
HSC Harsco
$6.56 /

+0.04 (+0.61%)

07/20/22 DA Davidson
Harsco price target lowered to $13 from $16 at DA Davidson
07/18/22 Barrington
Harsco price target lowered to $13 from $20 at Barrington
07/12/22 BMO Capital
Harsco initiated with a Market Perform at BMO Capital
05/04/22 Barrington
Harsco price target lowered to $20 from $22 at Barrington
VNT Vontier
$24.16 /

-0.315 (-1.29%)

HSC Harsco
$6.56 /

+0.04 (+0.61%)

Earnings
Checkpoint Therapeutics reports Q2 EPS (16c), consensus (17c) » 08:05
08/12/22
08/12
08:05
08/12/22
08:05
CKPT

Checkpoint Therapeutics

$1.26 /

+0.03 (+2.44%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CKPT Checkpoint Therapeutics
$1.26 /

+0.03 (+2.44%)

CKPT Checkpoint Therapeutics
$1.26 /

+0.03 (+2.44%)

07/14/22 B. Riley
Checkpoint Therapeutics resumed with a Buy at B. Riley
06/17/22 Lake Street
Checkpoint cosibelimab data 'competitive,' says Lake Street
06/07/22 Lake Street
Lake Street says Checkpoint warrants interest after cosibelimab 'shines' at ASCO
05/31/22 Cantor Fitzgerald
Cantor sees 'positive' data likely coming from Checkpoint Therapeutics in June
CKPT Checkpoint Therapeutics
$1.26 /

+0.03 (+2.44%)

CKPT Checkpoint Therapeutics
$1.26 /

+0.03 (+2.44%)

Hot Stocks
Longeveron expects cash to cover requirements into 1H24 » 08:04
08/12/22
08/12
08:04
08/12/22
08:04
LGVN

Longeveron

$5.96 /

-0.17 (-2.77%)

Cash and short-term…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LGVN Longeveron
$5.96 /

-0.17 (-2.77%)

LGVN Longeveron
$5.96 /

-0.17 (-2.77%)

03/24/22 Maxim
Maxim starts Longeveron at Buy, sees stock as 'inexpensive later-stage play'
03/24/22 Maxim
Longeveron initiated with a Buy at Maxim
01/05/22 EF Hutton
Longeveron initiated with a Buy at EF Hutton
LGVN Longeveron
$5.96 /

-0.17 (-2.77%)

LGVN Longeveron
$5.96 /

-0.17 (-2.77%)

Downgrade
ResMed downgraded to Neutral at Citi on valuation » 08:04
08/12/22
08/12
08:04
08/12/22
08:04
RMD

ResMed

$241.21 /

-2.37 (-0.97%)

Citi analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RMD ResMed
$241.21 /

-2.37 (-0.97%)

RMD ResMed
$241.21 /

-2.37 (-0.97%)

06:33 Today RBC Capital
ResMed downgraded to Sector Perform at RBC Capital on valuation
06:18 Today RBC Capital
ResMed downgraded to Sector Perform from Outperform at RBC Capital
06:18 Today Citi
ResMed downgraded to Neutral from Buy at Citi
06/06/22 RBC Capital
ResMed upgraded to Outperform from Sector Perform at RBC Capital
RMD ResMed
$241.21 /

-2.37 (-0.97%)

RMD ResMed
$241.21 /

-2.37 (-0.97%)

Earnings
VYNE Therapeutics reports Q2 adjusted EPS (13c) vs (35c) last year » 08:04
08/12/22
08/12
08:04
08/12/22
08:04
VYNE

VYNE Therapeutics

/

+

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VYNE VYNE Therapeutics
/

+

VYNE VYNE Therapeutics
/

+

08/10/22 H.C. Wainwright
VYNE Therapeutics price target lowered to $1.50 from $7 at H.C. Wainwright
01/13/22 Roth Capital
Roth raises Journey Medical target to $17 after dermatology assets acquisition
12/06/21 H.C. Wainwright
VYNE Therapeutics assumed with a Buy at H.C. Wainwright
08/13/21 Northland
VYNE Therapeutics price target lowered to $6 from $12 at Northland
VYNE VYNE Therapeutics
/

+

Earnings
Longeveron reports Q2 EPS (27c), consensus (23c) » 08:03
08/12/22
08/12
08:03
08/12/22
08:03
LGVN

Longeveron

$5.96 /

-0.17 (-2.77%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LGVN Longeveron
$5.96 /

-0.17 (-2.77%)

LGVN Longeveron
$5.96 /

-0.17 (-2.77%)

03/24/22 Maxim
Maxim starts Longeveron at Buy, sees stock as 'inexpensive later-stage play'
03/24/22 Maxim
Longeveron initiated with a Buy at Maxim
01/05/22 EF Hutton
Longeveron initiated with a Buy at EF Hutton
LGVN Longeveron
$5.96 /

-0.17 (-2.77%)

LGVN Longeveron
$5.96 /

-0.17 (-2.77%)

Recommendations
Oppenheimer says Leafly valuation 'beginning to look attractive' » 08:02
08/12/22
08/12
08:02
08/12/22
08:02
LFLY

Leafly

$2.25 /

-0.15 (-6.25%)

Oppenheimer analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LFLY Leafly
$2.25 /

-0.15 (-6.25%)

LFLY Leafly
$2.25 /

-0.15 (-6.25%)

07:32 Today Cowen
Leafly price target lowered to $4 from $12 at Cowen
06:12 Today Benchmark
Leafly price target lowered to $6.50 from $12.00 at Benchmark
05/20/22 Cowen
Cowen starts Leafly with Outperform with its early mover advantage
05/20/22 Cowen
Leafly initiated with an Outperform at Cowen
LFLY Leafly
$2.25 /

-0.15 (-6.25%)

LFLY Leafly
$2.25 /

-0.15 (-6.25%)

LFLY Leafly
$2.25 /

-0.15 (-6.25%)

Earnings
Crinetics reports Q2 EPS (81c), consensus (67c) » 08:02
08/12/22
08/12
08:02
08/12/22
08:02
CRNX

Crinetics

$20.58 /

-1.12 (-5.16%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRNX Crinetics
$20.58 /

-1.12 (-5.16%)

CRNX Crinetics
$20.58 /

-1.12 (-5.16%)

06/15/22 Evercore ISI
Crinetics added to Best SMID 'Core' Ideas list at Evercore ISI
11/30/21 JMP Securities
Crinetics initiated with an Outperform at JMP Securities
11/23/21 Evercore ISI
Evercore starts 'rare endo treasure trove' Crinetics at Outperform
11/23/21 Evercore ISI
Crinetics initiated with an Outperform at Evercore ISI
CRNX Crinetics
$20.58 /

-1.12 (-5.16%)

  • 13
    Apr
  • 21
    Oct
CRNX Crinetics
$20.58 /

-1.12 (-5.16%)

Earnings
PepGen reports Q2 EPS ($1.23) vs ($6.03) last year » 08:01
08/12/22
08/12
08:01
08/12/22
08:01
PEPG

PepGen

$11.15 /

-0.27 (-2.36%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PEPG PepGen
$11.15 /

-0.27 (-2.36%)

PEPG PepGen
$11.15 /

-0.27 (-2.36%)

05/31/22 Wedbush
PepGen initiated with an Outperform at Wedbush
05/31/22 Stifel
PepGen initiated with a Buy at Stifel
05/31/22 SVB Leerink
PepGen initiated with an Outperform at SVB Leerink
05/31/22 BofA
PepGen initiated with a Buy at BofA
PEPG PepGen
$11.15 /

-0.27 (-2.36%)

  • 06
    May
PEPG PepGen
$11.15 /

-0.27 (-2.36%)

Recommendations
System1 price target lowered to $19 from $26 at DA Davidson » 08:01
08/12/22
08/12
08:01
08/12/22
08:01
SST

System1

$8.69 /

+0.045 (+0.52%)

DA Davidson analyst Tom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SST System1
$8.69 /

+0.045 (+0.52%)

SST System1
$8.69 /

+0.045 (+0.52%)

07:06 Today Benchmark
System1 price target lowered to $13 from $15 at Benchmark
07/11/22 BofA
BofA starts System1 at Buy with $12 price target
07/11/22 BofA
System1 initiated with a Buy at BofA
04/26/22 Evercore ISI
System1 initiated with an In Line at Evercore ISI
SST System1
$8.69 /

+0.045 (+0.52%)

SST System1
$8.69 /

+0.045 (+0.52%)

SST System1
$8.69 /

+0.045 (+0.52%)

Earnings
BIO-key sees 2022 revenue $10M-$13M » 08:01
08/12/22
08/12
08:01
08/12/22
08:01
BKYI

BIO-key

$2.15 /

+0.115 (+5.65%)

"BIO-key has built a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BKYI BIO-key
$2.15 /

+0.115 (+5.65%)

BKYI BIO-key
$2.15 /

+0.115 (+5.65%)

Downgrade
Wrap Technologies downgraded to Neutral from Buy at Ladenburg » 08:01
08/12/22
08/12
08:01
08/12/22
08:01
WRAP

Wrap Technologies

$2.07 /

+0.22 (+11.89%)

Ladenburg analyst Jon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WRAP Wrap Technologies
$2.07 /

+0.22 (+11.89%)

WRAP Wrap Technologies
$2.07 /

+0.22 (+11.89%)

03/11/22 Ladenburg
Wrap Technologies price target lowered to $5.25 from $6.25 at Ladenburg
01/25/22 Maxim
Wrap Technologies downgraded to Hold at Maxim on management departures
01/25/22 Maxim
Wrap Technologies downgraded to Hold from Buy at Maxim
01/03/22 Ladenburg
Ladenburg uncovers 'significant loss' of future sales for Wrap Technologies
WRAP Wrap Technologies
$2.07 /

+0.22 (+11.89%)

Earnings
BIO-key reports Q2 EP (21c) vs. (15c) last year » 08:00
08/12/22
08/12
08:00
08/12/22
08:00
BKYI

BIO-key

$2.15 /

+0.115 (+5.65%)

Reports Q2 revenue $1.9M …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BKYI BIO-key
$2.15 /

+0.115 (+5.65%)

BKYI BIO-key
$2.15 /

+0.115 (+5.65%)

Options
Apple put buyer realizes 14% same-day gains » 08:00
08/12/22
08/12
08:00
08/12/22
08:00
AAPL

Apple

$168.49 /

-0.73 (-0.43%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$168.49 /

-0.73 (-0.43%)

AAPL Apple
$168.49 /

-0.73 (-0.43%)

08/11/22 Craig-Hallum
Enovix price target raised to $25 from $20 at Craig-Hallum
08/11/22 Loop Capital
Loop Capital has 'stronger conviction' in Enovix after 'customer milestones'
08/10/22 Bernstein
Apple Services performance fundamentally better than believed, says Bernstein
08/08/22 B. Riley
B. Riley thinks Globalstar's mystery satellite capacity customer is Apple
AAPL Apple
$168.49 /

-0.73 (-0.43%)

AAPL Apple
$168.49 /

-0.73 (-0.43%)

AAPL Apple
$168.49 /

-0.73 (-0.43%)

AAPL Apple
$168.49 /

-0.73 (-0.43%)

Recommendations
Roblox price target raised to $52 from $45 at Deutsche Bank » 07:56
08/12/22
08/12
07:56
08/12/22
07:56
RBLX

Roblox

$49.55 /

+1.52 (+3.16%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RBLX Roblox
$49.55 /

+1.52 (+3.16%)

RBLX Roblox
$49.55 /

+1.52 (+3.16%)

08/11/22 Wedbush
Roblox price target raised to $34 from $28 at Wedbush
08/10/22 Morgan Stanley
Roblox price target raised to $32 from $25 at Morgan Stanley
08/08/22 Truist
Roblox price target raised to $45 from $29 at Truist
08/01/22 MKM Partners
Roblox price target raised to $40 from $28 at MKM Partners
RBLX Roblox
$49.55 /

+1.52 (+3.16%)

RBLX Roblox
$49.55 /

+1.52 (+3.16%)

RBLX Roblox
$49.55 /

+1.52 (+3.16%)

RBLX Roblox
$49.55 /

+1.52 (+3.16%)

Recommendations
Oppenheimer encouraged as 'key initiatives taking hold' at CarMax » 07:56
08/12/22
08/12
07:56
08/12/22
07:56
KMX

CarMax

$101.64 /

+1.71 (+1.71%)

Oppenheimer analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KMX CarMax
$101.64 /

+1.71 (+1.71%)

KMX CarMax
$101.64 /

+1.71 (+1.71%)

07/14/22 Morgan Stanley
CarMax price target lowered to $124 from $140 at Morgan Stanley
06/27/22 RBC Capital
CarMax price target raised to $108 from $104 at RBC Capital
06/27/22 Wedbush
CarMax price target raised to $105 from $90 at Wedbush
06/27/22 Baird
CarMax valuation attractive for patient investors, says Baird
KMX CarMax
$101.64 /

+1.71 (+1.71%)

KMX CarMax
$101.64 /

+1.71 (+1.71%)

KMX CarMax
$101.64 /

+1.71 (+1.71%)

KMX CarMax
$101.64 /

+1.71 (+1.71%)

Recommendations
GeoPark price target lowered to $22 from $24 at Canaccord » 07:54
08/12/22
08/12
07:54
08/12/22
07:54
GPRK

GeoPark

$12.50 /

+0.55 (+4.60%)

Canaccord lowered the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GPRK GeoPark
$12.50 /

+0.55 (+4.60%)

GPRK GeoPark
$12.50 /

+0.55 (+4.60%)

Recommendations
ForgeRock price target raised to $20 from $15 at Deutsche Bank » 07:54
08/12/22
08/12
07:54
08/12/22
07:54
FORG

ForgeRock

$22.24 /

-1.13 (-4.84%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FORG ForgeRock
$22.24 /

-1.13 (-4.84%)

FORG ForgeRock
$22.24 /

-1.13 (-4.84%)

07:39 Today Cowen
ForgeRock price target lowered to $25 from $28 at Cowen
07/13/22 Piper Sandler
ForgeRock price target raised to $25 from $24 at Piper Sandler
06/22/22 JPMorgan
ForgeRock price target lowered to $30 from $36 at JPMorgan
05/12/22 Deutsche Bank
ForgeRock price target lowered to $15 from $16 at Deutsche Bank
FORG ForgeRock
$22.24 /

-1.13 (-4.84%)

  • 16
    Sep
FORG ForgeRock
$22.24 /

-1.13 (-4.84%)

Recommendations
Privia Health price target raised to $51 from $36 at Guggenheim » 07:53
08/12/22
08/12
07:53
08/12/22
07:53
PRVA

Privia Health

$37.81 /

+1.42 (+3.90%)

Guggenheim analyst Sandy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRVA Privia Health
$37.81 /

+1.42 (+3.90%)

PRVA Privia Health
$37.81 /

+1.42 (+3.90%)

07:49 Today Canaccord
Privia Health price target raised to $45 from $40 at Canaccord
07:41 Today Cowen
Privia Health price target raised to $44 from $35 at Cowen
07/14/22 Truist
Privia Health price target raised to $40 from $36 at Truist
06/29/22 Canaccord
Privia Health price target raised to $40 from $29 at Canaccord
PRVA Privia Health
$37.81 /

+1.42 (+3.90%)

  • 19
    Nov
PRVA Privia Health
$37.81 /

+1.42 (+3.90%)

Recommendations
2seventy Bio price target lowered to $28 from $42 at Canaccord » 07:51
08/12/22
08/12
07:51
08/12/22
07:51
TSVT

2seventy Bio

$16.58 /

-0.66 (-3.83%)

Canaccord analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSVT 2seventy Bio
$16.58 /

-0.66 (-3.83%)

TSVT 2seventy Bio
$16.58 /

-0.66 (-3.83%)

07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
05/02/22 Goldman Sachs
2seventy Bio initiated with a Buy at Goldman Sachs
02/10/22 SVB Leerink
SVB Leerink bullish on 2seventy Bio, initiates with an Outperform
02/10/22 SVB Leerink
2seventy Bio initiated with an Outperform at SVB Leerink
TSVT 2seventy Bio
$16.58 /

-0.66 (-3.83%)

TSVT 2seventy Bio
$16.58 /

-0.66 (-3.83%)

TSVT 2seventy Bio
$16.58 /

-0.66 (-3.83%)

Recommendations
Karuna Therapeutics price target raised to $330 from $200 at Guggenheim » 07:51
08/12/22
08/12
07:51
08/12/22
07:51
KRTX

Karuna Therapeutics

$261.01 /

+2.05 (+0.79%)

Guggenheim analyst Yatin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$261.01 /

+2.05 (+0.79%)

KRTX Karuna Therapeutics
$261.01 /

+2.05 (+0.79%)

08/10/22 Wells Fargo
Karuna Therapeutics price target raised to $264 from $186 at Wells Fargo
08/09/22 Mizuho
Karuna Therapeutics price target raised to $276 from $190 at Mizuho
08/09/22 Citi
Zai Lab price target raised to $199 from $193 at Citi
08/09/22 BofA
Karuna Therapeutics price target raised to $261 from $160 at BofA
KRTX Karuna Therapeutics
$261.01 /

+2.05 (+0.79%)

  • 10
    Aug
  • 10
    Nov
KRTX Karuna Therapeutics
$261.01 /

+2.05 (+0.79%)

Recommendations
SunOpta price target raised to $14 from $12 at Canaccord » 07:50
08/12/22
08/12
07:50
08/12/22
07:50
STKL

SunOpta

$10.73 /

+1.815 (+20.36%)

Canaccord analyst Bobby…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STKL SunOpta
$10.73 /

+1.815 (+20.36%)

STKL SunOpta
$10.73 /

+1.815 (+20.36%)

02/25/22 Canaccord
SunOpta price target lowered to $12 from $15 at Canaccord
12/28/21 Lake Street
Lake Street names 18 small cap best ideas for 2022
11/11/21 Canaccord
SunOpta price target lowered to $15 from $20 at Canaccord
09/10/21 Cowen
Cowen starts SunOpta at Outperform with $15 price target
STKL SunOpta
$10.73 /

+1.815 (+20.36%)

STKL SunOpta
$10.73 /

+1.815 (+20.36%)

Recommendations
Privia Health price target raised to $45 from $40 at Canaccord » 07:49
08/12/22
08/12
07:49
08/12/22
07:49
PRVA

Privia Health

$37.81 /

+1.42 (+3.90%)

Canaccord analyst Richard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRVA Privia Health
$37.81 /

+1.42 (+3.90%)

PRVA Privia Health
$37.81 /

+1.42 (+3.90%)

07:41 Today Cowen
Privia Health price target raised to $44 from $35 at Cowen
07/14/22 Truist
Privia Health price target raised to $40 from $36 at Truist
06/29/22 Canaccord
Privia Health price target raised to $40 from $29 at Canaccord
05/13/22 Canaccord
Privia Health price target lowered to $29 from $44 at Canaccord
PRVA Privia Health
$37.81 /

+1.42 (+3.90%)

  • 19
    Nov
PRVA Privia Health
$37.81 /

+1.42 (+3.90%)

Recommendations
Pear Therapeutics price target lowered to $9 from $13 at Chardan » 07:48
08/12/22
08/12
07:48
08/12/22
07:48
PEAR

Pear Therapeutics

$2.25 /

+0.27 (+13.64%)

Chardan analyst Keay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PEAR Pear Therapeutics
$2.25 /

+0.27 (+13.64%)

PEAR Pear Therapeutics
$2.25 /

+0.27 (+13.64%)

06/24/22 BTIG
Pear Therapeutics price target lowered to $11 from $12 at BTIG
05/24/22 Cowen
Pear Therapeutics revenues raised on strong Rx growth, says Cowen
05/17/22 Chardan
Pear Therapeutics price target lowered to $13 from $16 at Chardan
05/17/22 Citi
Pear Therapeutics price target raised to $11 from $10 at Citi
PEAR Pear Therapeutics
$2.25 /

+0.27 (+13.64%)

PEAR Pear Therapeutics
$2.25 /

+0.27 (+13.64%)

PEAR Pear Therapeutics
$2.25 /

+0.27 (+13.64%)

Recommendations
Laird Superfood price target lowered to $5 from $6 at Canaccord » 07:46
08/12/22
08/12
07:46
08/12/22
07:46
LSF

Laird Superfood

$1.99 /

-0.145 (-6.79%)

Canaccord analyst Bobby…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LSF Laird Superfood
$1.99 /

-0.145 (-6.79%)

LSF Laird Superfood
$1.99 /

-0.145 (-6.79%)

05/13/22 Craig-Hallum
Laird Superfood price target lowered to $6 from $12 at Craig-Hallum
03/09/22 Craig-Hallum
Laird Superfood price target lowered to $12 from $20 at Craig-Hallum
03/09/22 Canaccord
Laird Superfood price target lowered to $12 from $17 at Canaccord
02/01/22 Craig-Hallum
Laird Superfood price target lowered to $20 from $40 at Craig-Hallum
LSF Laird Superfood
$1.99 /

-0.145 (-6.79%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.